General Catalyst Group Management, LLC

CIK 0001637946 · Q2 2026

13F Equity AUM

$188.5M

+2.7% QoQ

Positions

+2 QoQ

AUM Rank

#8,303

Top 66%

Skill Alpha (FF)

-7.6%/yr^ns

No Clear Edge

Rank #7,923 · Top 95%

vs S&P -34.7%/yr (unadj.)

Quarters Tracked

~5 years

Portfolio Concentration

Top 5: 93.1%Top 10: 99.0%Top 20: 100.0%

AVBP27.6%

Parabilis Medicines, Inc.23.2%

CART17.9%

MAZE16.4%

Odyssey Therapeutics, Inc.8.0%

Eikon Therapeutics, Inc.2.1%

GUTS2.1%

Ethos Technologies, Inc.0.7%

CPNG0.5%

AMZN0.5%

Others (4)1.0%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare46.0%

Unclassified34.1%

Consumer Cyclical19.1%

Other0.8%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 14Median: 1.39%Avg: 7.14%

0–0.5%

5(1.5%)

0.5–1%

2(1.2%)

1–3%

2(4.2%)

3–5%

0(0.0%)

5%+

5(93.1%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 14vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New4Increased3Decreased1Exited2

New Positions

Parabilis Medicines,…23.2%

+1.6M

Odyssey Therapeutics…8.0%

+810K

DASH0.3%

+3K

CVNA0.2%

+6K

Increased

CPNG0.5%

+18K(+49%)

AMZN0.5%

+1K(+50%)

META0.4%

+662(+101%)

Decreased

GUTS2.1%

-7(0%)

Exited

IOT

-2,000,000

GTLB

-921,405

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...